$53.01
+1.53 (+2.97%)
Performance
1D
—
1W
—
1M
—
3M
-4.61%
6M
+16.10%
1Y
+67.81%
YTD
+14.10%
Open$50.82
Previous Close$51.48
Day High$53.39
Day Low$50.82
52W High$65.00
52W Low$28.09
Volume—
Avg Volume1.69M
Market Cap7.43B
P/E Ratio—
EPS$-5.63
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$49.46
Above
SMA 200
$39.88
Above
RSI (14)
62.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
17 analysts
Price Target
+26.5% upside
Current
$53.01
$53.01
Target
$67.08
$67.08
$56.09
$67.08 avg
$108.72
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 3.07B | 3.02B | 2.41B |
| Net Income | 147.42M | 150.65M | 124.53M |
| Profit Margin | 4.8% | 5.0% | 5.2% |
| EBITDA | 264.93M | 279.22M | 238.21M |
| Free Cash Flow | 132.34M | 114.72M | 94.55M |
| Rev Growth | +1.9% | +8.9% | +10.2% |
| Debt/Equity | 1.24 | 1.35 | 1.48 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |